SCHEMBL32688008

SCHEMBL32688008

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C#N)c1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ PDE9A O76083 1/20 0.42
▸ HSD11B1 P28845 8/20 0.41
▸ HSD11B2 P80365 1/20 0.41
▸ ACMSD Q8TDX5 1/20 0.41
▸ POLB P06746 4/20 0.40
▸ CXCR2 P25025 1/20 0.40
▸ BRD4 O60885 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ TNF P01375 1/20 0.38
▸ PLA2G1B P04054 1/20 0.38
▸ NOD2 Q9HC29 1/20 0.38
▸ NOD1 Q9Y239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688370 0.93 POLB (0.41) MEN1KMT2APDE9AHSD11B1HSD11B2
SCHEMBL32688269 0.92 HSD11B1 (0.45) MEN1KMT2AHSD11B1ACMSDPOLB
SCHEMBL32688166 0.92 HSD11B1 (0.41) MEN1KMT2APDE9AHSD11B1HSD11B2
SCHEMBL32688160 0.91 HSD11B1 (0.36) HSD11B1HSD11B2IDO1ADORA3ADORA2A
SCHEMBL32688034 0.91 PDE9A (0.43) MEN1KMT2APDE9APOLBCXCR2
SCHEMBL32688414 0.90 DHODH (0.40) PDE9AHSD11B1HSD11B2IDO1ADORA3
SCHEMBL32688028 0.90 HSD11B1 (0.47) MEN1KMT2APDE9AHSD11B1HSD11B2
SCHEMBL32688201 0.89 HSD11B1 (0.36) PDE9AHSD11B1HSD11B2CXCR2IDO1
SCHEMBL32688050 0.89 HSD11B1 (0.44) HSD11B1HSD11B2POLBCXCR2BRD4
SCHEMBL32688133 0.89 HSD11B1 (0.39) PDE9AHSD11B1HSD11B2IDO1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MEN1 4353/4885KMT2A 3400/4885PDE9A 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback